Inactive Instrument
Stemcell Holdings, Inc. Share Price Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 16.43L | |
| -0.76% | +2.55% | +44.40% | -0.57% | 8.33TCr | |
| -3.78% | +115.65% | +448.36% | +23.40% | 5.79TCr | |
| +0.48% | +23.89% | -21.93% | -35.75% | 5.78TCr | |
| +1.42% | +1.61% | -0.67% | +34.08% | 5.17TCr | |
| -0.77% | +2.14% | +9.45% | +170.00% | 4.93TCr | |
| -0.01% | +3.42% | +58.62% | -17.58% | 3.2TCr | |
| -0.02% | +3.43% | +50.70% | +98.86% | 2.59TCr | |
| -2.83% | +6.08% | +0.05% | +223.58% | 2.27TCr | |
| -1.74% | -1.27% | +55.75% | +107.91% | 1.69TCr | |
| Average | -0.78% | +20.75% | +71.64% | +67.11% | 4.42TCr | |
| Weighted average by Cap. | -0.77% | +25.31% | +82.92% | +46.02% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 33.39L 28.61L 26.77L 24.47L 46.18L 32Cr 46.67L 3.17Cr 1.23Cr 16Cr 1.25Cr 1.23Cr 53Cr | 61.8L 52.96L 49.55L 45.3L 85.48L 59Cr 86.39L 5.86Cr 2.28Cr 30Cr 2.32Cr 2.27Cr 98Cr |
| Net income | 14.02L 12.02L 11.24L 10.28L 19.4L 13Cr 19.6L 1.33Cr 51.73L 6.74Cr 52.66L 51.52L 22Cr | 24.1L 20.65L 19.32L 17.66L 33.33L 23Cr 33.69L 2.29Cr 88.89L 12Cr 90.48L 88.52L 38Cr |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
